INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER
A CPT inhibitor compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof: or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of treating a subject having cancer comprises administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof.
-
Page/Page column 86
(2008/12/07)
More Articles about upstream products of 1059702-76-9